Safety and efficacy of carbon fiber–reinforced polyetheretherketone implants in primary and metastatic spinal tumors: a systematic review and meta-analysis
European Spine Journal · 30.07.2026
DOI: 10.1007/s00586-026-10223-9 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Spine Journal, online erschienen am 30.07.2026. Verfasst von Leonardo Di Cosmo und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, Humanitas University, Rozzano, Italy. leonardo.dicosmo@st.hunimed.eu. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 52 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Carbon fiber-reinforced polyetheretherketone (CFRP) instrumentation is increasingly used to manage primary and metastatic spinal tumors due to its radiolucency and similar biomechanical properties to titanium implants, which facilitate radiotherapeutic planning and postoperative surveillance. However, whether these advantages translate into comparable or improved clinical outcomes relative to conventional instrumentation is unclear. METHODS: Following PRISMA guidelines, databases were searched through November 2025 for studies evaluating CFRP instrumentation in adults undergoing surgery for primary or metastatic spinal tumors. Randomized controlled trials, prospective, and retrospective studies reporting at least one clinical outcome were included. Random-effects models were applied, with relative risks (RR) used for dichotomous outcomes and mean differences (MD) for continuous outcomes. RESULTS: A total of 1,609 patients were included, comprising 1,421 treated with CFRP and 188 with titanium instrumentation. Single-arm pooled prevalence analyses included all eligible studies, whereas comparative analyses were restricted to the four studies directly comparing CFRP and titanium instrumentation. The pooled hardware failure rate for CFRP was 3.5% (95% CI 2.3-5.2%), infection rate 3.9% (95% CI 2.1-7.3%), reoperation rate 6.2% (95% CI 3.8-9.8%), and recurrence rate 10.0% (95% CI 6.3-15.6%). Comparative analyses demonstrated no significant differences between CFRP and titanium instrumentation for hardware failure (RR 1.17, 95% CI 0.35-3.97; p=0.796), infection (RR 0.70, 95% CI 0.17-2.97; p=0.632), reoperation (RR 2.88, 95% CI 0.68-12.21; p=0.150), or tumor recurrence (RR 0.50, 95% CI 0.21-1.18; p=0.113). Operative time, length of stay, and survival analyses varied significantly across studies and were inconsistently reported, precluding pooled analyses. CONCLUSION: In patients undergoing surgery for primary and metastatic spinal tumors, CFRP instrumentation shows complication, reoperation, and recurrence rates comparable to titanium implants. However, whether these advantages translate into improved long-term survival outcomes remains unclear. The current literature is largely observational, with limited follow-up and heterogeneity in patient populations and adjuvant treatments. Further prospective, multicenter, and propensity-matched studies are needed to clarify the impact of CFRP instrumentation on long-term outcomes and to define its role in spinal oncologic surgery.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biomedical Sciences, Humanitas University, Rozzano, Italy. leonardo.dicosmo@st.hunimed.eu.
- Department of Biomedical Sciences, Humanitas University, Rozzano, Italy.
- Escola Superior de Ciências da Santa Casa de Misericórdia de VitóriaEscola Superior de Ciências da Santa Casa de Misericórdia de Vitória (EMESCAM), Vitória, Brazil.
- Department of Neurosurgery, Catholic University of the Sacred Heart, Milan, Italy.
- Department of Neurological Surgery, University of Louisville, Louisville, United States.
- Department of Neurosurgery, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.
ORCID-Profile: Leonardo Di Cosmo
Zitieren
APA
Di Cosmo, L., Barak, E. F., El Choueiri, J., Imbrogno, C. P., Carretta, L. T. A., De Rossi, L., Ranalli, C., Simione, J. D., Kasem, R. A., & Zaed, I. (2026). Safety and efficacy of carbon fiber–reinforced polyetheretherketone implants in primary and metastatic spinal tumors: a systematic review and meta-analysis. European Spine Journal. https://doi.org/10.1007/s00586-026-10223-9
Vancouver
Di Cosmo L, Barak EF, El Choueiri J, Imbrogno CP, Carretta LTA, De Rossi L, et al. Safety and efficacy of carbon fiber–reinforced polyetheretherketone implants in primary and metastatic spinal tumors: a systematic review and meta-analysis. European Spine Journal. 2026. doi:10.1007/s00586-026-10223-9
BibTeX
@article{DiCosmo2026,
author = {Di Cosmo, Leonardo and Barak, Ely Feffer and El Choueiri, Jad and Imbrogno, Christopher Peter and Carretta, Lucca Tamara Alves and De Rossi, Lorenzo and Ranalli, Carlotta and Simione, Jordan Donna and Kasem, Rahim Abo and Zaed, Ismail},
title = {Safety and efficacy of carbon fiber–reinforced polyetheretherketone implants in primary and metastatic spinal tumors: a systematic review and meta-analysis},
journal = {European Spine Journal},
year = {2026},
doi = {10.1007/s00586-026-10223-9}
}
EUVIMED